Corticosteroids in Respiratory Disorders

Corticosteroids in Respiratory Disorders

Corticosteroids in Respiratory Disorders

On this page

MoA & Classification - Steroid Superpowers

  • Mechanism of Action (MoA): Potent anti-inflammatory.
    • Genomic (slow): Bind cytosolic Glucocorticoid Receptors (GR) → complex to nucleus:
      • ↑ Lipocortin-1 (Annexin A1) → inhibits $PLA_2$ → ↓ PGs, LTs.
      • ↓ Pro-inflammatory genes ($NF-\kappa B$, AP-1 blocked).
    • Non-Genomic (rapid): Via membrane GRs.
  • Types: Glucocorticoids (anti-inflammatory) vs. Mineralocorticoids (salt-retaining). Focus: Glucocorticoids.
  • Classification (Glucocorticoids):
    • Systemic (Oral/IV):
      • Short (8-12h): Hydrocortisone.
      • Intermediate (12-36h): Prednisolone, Methylprednisolone.
      • Long (36-72h): Dexamethasone.
    • Inhaled (ICS): Beclomethasone, Budesonide, Fluticasone (local action, ↓ systemic SEs). 📌 Potency: Hydrocortisone (1) < Prednisolone (4) < Methylprednisolone (5) < Dexamethasone (25).

⭐ Corticosteroids upregulate $\beta_2$-adrenergic receptors, enhancing bronchodilator responsiveness.

Inhaled Corticosteroids (ICS) - Puff Power

  • Common ICS: Beclomethasone, Budesonide, Fluticasone, Ciclesonide, Mometasone.
  • Delivery Devices:
    • MDI: Adv: Portable. Disadv: Needs coordination. Spacer improves delivery, ↓ local S/E.
    • DPI: Adv: Breath-actuated. Disadv: Needs good inspiratory flow.
    • Nebulizers: Adv: For severe attacks/uncooperative patients. Disadv: Less portable. Valved holding chamber with mask components and use
  • Pharmacokinetics:
    • High first-pass metabolism (e.g., Fluticasone, Budesonide) crucial for low systemic effects.
    • Ciclesonide: Prodrug activated in lungs, minimizing local and systemic side effects.
  • Local Side Effects & Prevention:
    • Oropharyngeal candidiasis (thrush), dysphonia (hoarseness).
    • Prevention: Use spacer with MDI; rinse mouth thoroughly with water and spit after inhalation.

Ciclesonide is a prodrug activated in the lungs, minimizing local side effects like candidiasis.

Systemic Steroids: Indications - System Savers

Systemic corticosteroids (Oral - OCS; Intravenous - IVCS) are vital for managing acute and severe respiratory conditions.

  • Core Indications (OCS/IVCS):

    • Acute Severe Asthma: Rapidly reduces airway inflammation and obstruction.
    • COPD Exacerbations: Shortens recovery time, improves FEV1 & PaO2, reduces relapse risk.
    • Chronic Severe Asthma (Refractory): For patients not controlled on high-dose ICS/LABA.
    • Sarcoidosis: Symptomatic pulmonary disease (e.g., Stage II/III with significant symptoms/lung function impairment).
    • Interstitial Lung Diseases (ILDs):
      • Cryptogenic Organizing Pneumonia (COP)
      • Nonspecific Interstitial Pneumonia (NSIP) (especially cellular variant)
    • ARDS (Acute Respiratory Distress Syndrome): Selected cases (e.g., early moderate-severe ARDS, COVID-19 related), benefits controversial, dose & timing critical.
  • Dosing Principles & Examples:

    • "Burst" Therapy (Acute Exacerbations):
      • Prednisolone (Oral): 40-50 mg/day for 5-7 days (Asthma/COPD). No tapering needed for short courses.
    • Longer Courses (>2-3 weeks): Gradual tapering is essential to prevent adrenal insufficiency.
    • Route Selection:
      • Oral (PO): Prednisolone is preferred if patient can tolerate oral intake.
      • Intravenous (IV): Methylprednisolone (e.g., 60-128 mg/day in divided doses for severe asthma), Hydrocortisone (e.g., 100-200 mg IV stat then q6h for status asthmaticus). Use for severe cases or if unable to take orally.

⭐ For acute asthma exacerbations, oral corticosteroids are as effective as intravenous corticosteroids if the patient can tolerate oral intake and there are no concerns about absorption.

Flowchart: Steroid Use in Acute Asthma Exacerbation

Adverse Effects & Management - Steroid Alerts

Effect TypeAdverse EffectsPrevention / Management
Local (ICS)Oropharyngeal candidiasis, dysphonia, cough.Spacer, mouth rinsing.
Systemic (OCS / High-dose ICS)HPA axis suppression, Cushingoid features (📌 CUSHINGOID), osteoporosis, hyperglycemia, immunosuppression, cataracts, glaucoma, skin thinning, mood changes, PUD.Lowest effective dose, shortest duration, calcium/Vit D, bone density monitoring, PPI if needed, regular check-ups.

Key Cautions:

  • Active untreated infections (esp. TB, fungal), live vaccines (with high dose systemic), peptic ulcer disease, uncontrolled diabetes/hypertension.

Steroid Withdrawal Syndrome:

  • Abrupt cessation: fatigue, myalgia, arthralgia, hypotension. Taper dose.

⭐ Alternate day therapy with short-acting oral corticosteroids like prednisolone can reduce HPA axis suppression in long-term use.

High‑Yield Points - ⚡ Biggest Takeaways

  • Inhaled Corticosteroids (ICS) like Budesonide & Fluticasone are first-line for persistent asthma.
  • Systemic corticosteroids (e.g., Prednisolone) manage acute asthma/COPD exacerbations.
  • MOA: Broad anti-inflammatory effects, ↓ cytokines & eosinophils.
  • ICS adverse effects: Oral thrush, dysphonia; mitigate with spacer & mouth rinsing.
  • Systemic risks: Hyperglycemia, osteoporosis, HPA axis suppression, immunosuppression.
  • Budesonide is the safest ICS during pregnancy.
  • Also indicated for ABPA and pulmonary sarcoidosis.

Practice Questions: Corticosteroids in Respiratory Disorders

Test your understanding with these related questions

A 3-year-old is diagnosed with severe acute asthma exacerbation. Which medication is given first?

1 of 5

Flashcards: Corticosteroids in Respiratory Disorders

1/10

_____ is a systemic steroid used for maintenance therapy after an acute exacerbation of asthma.

TAP TO REVEAL ANSWER

_____ is a systemic steroid used for maintenance therapy after an acute exacerbation of asthma.

Prednisolone

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial